Aquaculture Vaccines Market Value To Hit $290 Million By 2025

The Canada aquaculture vaccines market is one of the largest in the world and is projected to expand at a CAGR of 6.3% over the forecast period. During the forecast timeframe, the country will continue to grow at a global level. Increasing investments in the research and development of aquaculture vaccines by major players in Canada, such as Merck Animal Health and Zoetis, will augment the growth during the projected years.

The inactivated vaccines market was valued at around USD $158.2 million in the year 2018. Inactivated vaccines were introduced with an aim to protect the aquaculture species against any disease outbreaks. When disease outbreaks, such as bacterial and viral infections occur, diagnostics are conducted to identify the cause, and then appropriate treatments are taken into consideration. Inactivated vaccines are much more efficient in treating such diseases, thus reflecting an upward trajectory in the aquaculture vaccines market over the forecast timeframe.

The immersion vaccines segment is estimated to witness a CAGR of 6.7% over the forecast timeframe. Immersion vaccines allow immune cells located in the fish’s gills and skin to become directly exposed to antigens. These immune cells may then witness antibody production, thus protecting the fish from future infections. Immersion vaccination occurs by means of dipping, depending on the size and species type. Hence, the growing efficiency of such vaccines will augment market growth.

The global Aquaculture Vaccines Market is poised to cross USD $290 million by 2025, according to a new research study published by Global Market Insights, Inc. Increasing prevalence of bacterial and viral infections among aquaculture species across the world is one of the major growth augmenting factors, since aquaculture vaccines are the most efficient form of treatment for such diseases. As per the National Institute of Health (NIH), bacterial diseases are the most prevalent disease challenge in fish farming, accounting for about 54.9% of cases worldwide. Hence, the rising incidence of such diseases will augment the aquaculture vaccines market growth over the forecast period.

Increasing aquaculture production around the globe, coupled with the development and launch of new aquaculture vaccines for different species, will further propel the market growth. For instance, as per the Food and Agriculture Organization of the United Nations (FAO), the production of salmon species has increased from 1.3 million to 2.2 million over the last decade.

Stringent regulatory policies for approval of aquaculture vaccines is one of the major growth impending factors. Moreover, some commercial vaccines for fish consist of mixtures of two to four vaccine products. Hence, such complex manufacturing procedure of vaccines, associated with high cost, will limit the growth of the aquaculture vaccines market. – PR Newswire